Skip to main content
Richard B. Cannon
( out of 729 reviews )

Richard B. Cannon, MD

Languages spoken: English, Spanish

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Clinic 1A, Head and Neck
1950 Circle of Hope
Salt Lake City , UT 84112

Richard Cannon, MD is a surgeon at the Huntsman Cancer Hospital and assistant professor of Otolaryngology – Head & Neck Surgery at the University of Utah. He is board-certified in Otolaryngology – Head & Neck Surgery and fellowship trained in head and neck surgical oncology, microvascular reconstruction, and advanced robotic surgery by the American Head and Neck Society (AHNS). He performs the full spectrum of head and neck cancer surgery, including diagnosis and treatment of tumors in the mouth, throat, voice box, nose and sinuses, salivary glands, thyroid, and neck. He has additional expertise in microvascular reconstruction following head and neck cancer surgery and minimally invasive robotic surgery for removal of tumors in the throat through the mouth (Transoral Robotic Surgery). He also performs advanced craniofacial trauma and skull base surgery. Dr. Cannon is dedicated to providing each patient with the absolute best possible outcome and treating patients with the same care he would provide members of his own family.

Dr. Cannon graduated cum laude from Pomona College, where he was inducted into the Phi Beta Kappa honor society, followed by medical school at the University of Texas Health Science Center at San Antonio, where he was inducted into the prestigious Alpha Omega Alpha honor medical society. He completed his residency training at the University of Utah, where he held the position of chief resident. He then completed his fellowship training at the University of Washington in Seattle with the world-renowned head and neck cancer and reconstructive surgeon, Neal D. Futran, MD, DMD.

Since completing his training, Dr. Cannon has dedicated himself to advanced reconstructive and oncologic care for patients with head and neck cancer. He is passionate about clinical outcomes research utilizing large national databases, in an effort to improve cancer survival. His research focuses on treatment for head and neck tumors and rehabilitation through surgery. Dr. Cannon has authored numerous studies in medical journals and book chapters, as well as given several national presentations related to living through head and neck cancer with the best functional and quality of life outcomes possible. He serves on the national committees (AAO-HNS) for Head and Neck Surgery and Oncology and (AHNS) Publications. Since his appointment at the University of Utah, he has worked towards improving patient’s outcomes, safety, and satisfaction. He is also on the University of Utah Robotic Surgery committee and currently serves as the medical director of the Huntsman Cancer Hospital’s inpatient surgical floor. Dr. Cannon also serves as the H&N Oncology Fellowship Director.

Dr. Cannon likes living in the Wasatch Mountains, where he enjoys water and snow skiing, biking, hiking, running, and playing soccer.

Board Certification

American Board of Otolaryngology - Head and Neck Surgery

Patient Rating

Patients consistently praise Dr. Cannon for clear, compassionate communication and for taking time to listen and answer questions without rushing. Many note his strong surgical skill and medical knowledge, which leaves them feeling confident and well cared for. Reviewers also highlight his responsiveness and the supportive, attentive care provided by his team.

Generated via Patient Reviews

4.9 /5
( out of 729 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Jun 30, 2026
MIDVALLEY

Dr Cannon is a kind, personable, and caring doctor. My husband and I always feel like we're meeting up with an old friend when we come in for my appointments.

Jun 03, 2026
HUNTSMAN CANCER CENTER

You're in good hands with this doctor!

May 28, 2026
HUNTSMAN CANCER CENTER

Dr Cannon is the best. 10/10 and five stars.

May 22, 2026
HUNTSMAN CANCER CENTER

I.was very impressed. Dr. Cannon carefully went through all the issues and options both positive and negative. I was left feeling that I was in ex excellent hands.

May 09, 2026
HUNTSMAN CANCER CENTER

Dr. Cannon took the time to listen to my questions and offered answers in 'non' medical language that I could understand.

May 08, 2026
HUNTSMAN CANCER CENTER

Great doctor

Apr 27, 2026
HUNTSMAN CANCER CENTER

Doctor Cannon is the finest doctor I have ever known.

Apr 17, 2026
HUNTSMAN CANCER CENTER

Dr Cannon is not only a fantastic surgeon, but he is an incredibly empathetic doctor. He truly understands that this is the most scary time of your life. I had a million and one questions, down to whether or not cosmetic procedures could fix any potential complications. He answered them all with no judgement. I always felt like I was his number one focus when meeting in person or on the phone. I felt safe and comfortable in his care and I really cannot recommend him enough. On top of that, my surgery was very successful and his care has left me feeling optimistic for full recovery.

Apr 03, 2026
HUNTSMAN CANCER CENTER

As always, Dr. Cannon is a careful and compassionate physician. Entire staff was efficient.

Mar 27, 2026
HUNTSMAN CANCER CENTER

Very knowledgeable and showed obvious concern

Mar 27, 2026
HUNTSMAN CANCER CENTER

Love Dr. Cannon. Only good thing about Cancer.

Mar 26, 2026
HUNTSMAN CANCER CENTER

Fantastic doctor period.....

Mar 22, 2026
HUNTSMAN CANCER CENTER

Dr. Cannon has twice called me directly to address my concerns. I expected a nurse to return my call by he did in a quick and efficient time. Very kind and respectful.

Mar 04, 2026
HUNTSMAN CANCER CENTER

I can not say enough about Dr.Cannon. He truly cares about my questions and my fears. He also gave my different options and let me decide my treatment. I am very grateful for him

Mar 03, 2026
HUNTSMAN CANCER CENTER

Dr. Cannon is exceptional ! He posseses a broad based wealth of knowledge and experience. Dr. Cannon is an excellent listener and communicates healthcare challenges and treatment options in a thoughtful caring manner. I always leave one of Dr. Cannon's appointments feeling that I was very well cared for.

Feb 15, 2026
HUNTSMAN CANCER CENTER

Doctor Cannon is why we travel hundreds of miles monthly to receive the finest medical care. He is friendly and caring. He is second to none.

Feb 14, 2026
HUNTSMAN CANCER CENTER

Dr Cannon is a great doctor, he explained what their goal is to get me back to a normal life for a treac patient

Feb 07, 2026
HUNTSMAN CANCER CENTER

Dr. Cannon is well met, personable, kind, caring, professional, and from what I felt in my first meeting with him, trustworthy.

Feb 06, 2026
HUNTSMAN CANCER CENTER

I would rate Dr Cannon a 9

Jan 24, 2026
HUNTSMAN CANCER CENTER

Very nice

Jan 20, 2026
HUNTSMAN CANCER CENTER

Unfortunately for me, I have met more doctors than I would have liked to and thank goodness for good doctors to care for me. Dr. Cannon is the fines doctor I have ever met. He is so knowledgeable but remains kind and humble. I believe he genuinely cares. I have never felt rushed or like a number. He sees me as a person. I consider myself extremely lucky to have Dr. Cannon as my oncologist.

Jan 19, 2026
HUNTSMAN CANCER CENTER

He is very good

Jan 10, 2026
HUNTSMAN CANCER CENTER

So far so good. Our surgery is scheduled in two weeks, so we'll see how that goes.

Dec 19, 2025
HUNTSMAN CANCER CENTER

Dr Cannon is amazing. He is very knowledgeable and shows compassion for his patients.

Dec 12, 2025
HUNTSMAN CANCER CENTER

A strong asset for Huntsman Center.

Nov 21, 2025
HUNTSMAN CANCER CENTER

If you find yourself in need of an oral cancer specialist, you can't do any better than Dr. Cannon.

Nov 21, 2025
HUNTSMAN CANCER CENTER

Knowledgeable and personable. Great experience.

Nov 15, 2025
HUNTSMAN CANCER CENTER

Extremely professional.

Nov 15, 2025
HUNTSMAN CANCER CENTER

Great Dr. personable. Caring. Talented

Nov 14, 2025
HUNTSMAN CANCER CENTER

Explained everything clearly and to the point. Look forward to seeing him again.

Nov 06, 2025
HUNTSMAN CANCER CENTER

Excellent Dr.

Oct 25, 2025
HUNTSMAN CANCER CENTER

Dr Richard B Cannon is a highly professional, clear communcator and informative doctor. His demeanor makes him easy to talk to, including addressing difficult medical topics.

Oct 11, 2025
HUNTSMAN CANCER CENTER

Dr Tanner is amazing. I would give him ten stars out of ten.

Oct 05, 2025
HUNTSMAN CANCER CENTER

Thank you for your caring and kind support.

Sep 09, 2025
HUNTSMAN CANCER CENTER

My experience as a whole was amazing. My only suggestion is that when family is in the waiting room during surgery - that someone would come speak with them about the outcome once it has been completed. This didn't happen and my husband was left in the dark until the nurse in recovery called to say they were taking me to my room.

Aug 31, 2025
HUNTSMAN CANCER CENTER

I am truly grateful for Dr Cannon's skill and compassion.

Aug 23, 2025
HUNTSMAN CANCER CENTER

Great doctor. Great surgeon. Very knowledgeable for his patients and field of study. Excellent doctor, listen to his patients, answer questions about your medical condition. Provide options for your treatment. I would recommend him and Huntsman Hospital, to everyone.

Aug 22, 2025
HUNTSMAN CANCER CENTER

First Class individual and Surgeon.

Aug 12, 2025
HUNTSMAN CANCER CENTER

If you find yourself needing exceptional treatment and care for oral cancer, I can't imagine a better oncologist than Richard Cannon. I have no fears or worries knowing my case is in his hands.

Aug 11, 2025
HUNTSMAN CANCER CENTER

Very personable, knowledgeable. He is very approachable and easy to ask questions about pertinent health care conditions related to me

Aug 08, 2025
HUNTSMAN CANCER CENTER

Treated me very quickly when the cancer was found.

Aug 03, 2025
HUNTSMAN CANCER CENTER

Dr. Cannon started and ended our talks with insightful positivity. He listened to my concerns and expressed his. No sugercoating just honest answers to my questions and thoughtfully answered my concerns.

Jun 13, 2025
HUNTSMAN CANCER CENTER

He was very professional but also kind.

May 19, 2025
HUNTSMAN CANCER CENTER

Outstanding. He listened, discussed treatment, made me totally comfortable

May 04, 2025
HUNTSMAN CANCER CENTER

Dr Cannon is wonderful. He is the doctor you always wished you had. Caring, understanding, thoughtful, and very smart. He is a gifted surgeon to boot! He will explain thing to you and make a decision with you and not for you. All around great guy. I consider myself lucky that he took me on as a patient. He took wonderful care of me because he genuinely cares.

Apr 29, 2025
HUNTSMAN CANCER CENTER

Very nice guy. Seemed to care and made special efforts to be sure I understood my condition and treatment.

Apr 26, 2025
HUNTSMAN CANCER CENTER

Doctor and his staff were great. Very professional and kept me in the loop about everything going on with my visit.

Apr 10, 2025
HUNTSMAN CANCER CENTER

Dr. Cannon was very knowledgeable in his assessment of my medical condition which others had failed to diagnose even after 3 biopsies. He was clear in his explanation and treatment plan. I am now confident knowing that my cancer is treatable and I am in the care of a skilled and competent surgeon.

Mar 01, 2025
HUNTSMAN CANCER CENTER

Dr. Cannon is an amazing doctor. I know cancer is a tricky business but I feel very confident Dr. Cannon is out for my best interest as I am sure he is with everyone else. I am very thankful for both him and his team that worked on me.

Feb 27, 2025
HUNTSMAN CANCER CENTER

Dr. Cannon is careful and empathetic. The staff is helpful.

Feb 04, 2025
HUNTSMAN CANCER CENTER

Very good bedside manner. Took the time to explain post operative progress. Listened to and answered my questions and concerns.

Jan 18, 2025
HUNTSMAN CANCER CENTER

Simply the best!9

Jan 16, 2025
HUNTSMAN CANCER CENTER

Dr. Cannon is thorough, provides clear explanations, answers every question, and provides exceptional care. We can't say enough about how much we appreciate his expertise and compassion.

Dec 22, 2024
HUNTSMAN CANCER CENTER

Great doctor very good at what he does and knows

Dec 20, 2024
HUNTSMAN CANCER CENTER

Very caring and thoughtful

Dec 20, 2024
HUNTSMAN CANCER CENTER

We are just beginning to work with him an so we can't fully judge him and his performance at this point.

Dec 13, 2024
HUNTSMAN CANCER CENTER

Dr. Cannon actually cares about his patience. I am always surprised that he is willing to take the team needed. I never feel rushed and I always feel that I matter.

Dec 08, 2024
HUNTSMAN CANCER CENTER

Dr. Cannon always takes time to listen to me and asks many questions regarding my health. He is an exceptional doctor and an exceptional person.

Nov 22, 2024
HUNTSMAN CANCER CENTER

Very knowledgeable and caring. about my health. Shared our options for treatment and took the time to make sure we understand the treatments available. Very nice and caring Doctor. The best.

Nov 19, 2024
HUNTSMAN CANCER CENTER

This is NOW my second time here with Dr Cannon, none finer!!!

Nov 02, 2024
HUNTSMAN CANCER CENTER

I don't wish any ill to anyone but if they are diagnosed with an illness that requires emergency care with long term life changes, I will recommend Dr. Cannon and his staff along with the Huntsman Center. I received the upmost care from the first phone call that was made and have been treated with the upmost respect and dignity.

Nov 01, 2024
HUNTSMAN CANCER CENTER

Very nice and informative

Nov 01, 2024
HUNTSMAN CANCER CENTER

Richard B Cannon, MD listened to my limits for pain control and followed my wishes. I cannot use opioid drugs as they make pain much worse for me, Dr Cannon did my surgery without opioids and I recovered quickly. He cares about his patients and has great skill in the operating room.

Oct 31, 2024
HUNTSMAN CANCER CENTER

This individual, along with Dr Hunt, are incredibly gifted surgeons! Not to mention the nursing staff, and physical therapists!!!

Oct 18, 2024
HUNTSMAN CANCER CENTER

Very professional yet down to earth very relatable

Oct 01, 2024
HUNTSMAN CANCER CENTER

I feel very fortunate to be in Dr. Cannon's care.

Sep 30, 2024
HUNTSMAN CANCER CENTER

Dr. Cannon was great at easing any concerns. He gave multiple options, and let me decide what I felt was the route I was comfortable with. He also made sure I have an easy path in the future to reach out again.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Richard Cannon, MD is a surgeon at the Huntsman Cancer Hospital and assistant professor of Otolaryngology – Head & Neck Surgery at the University of Utah. He is board-certified in Otolaryngology – Head & Neck Surgery and fellowship trained in head and neck surgical oncology, microvascular reconstruction, and advanced robotic surgery by the American Head and Neck Society (AHNS). He performs the full spectrum of head and neck cancer surgery, including diagnosis and treatment of tumors in the mouth, throat, voice box, nose and sinuses, salivary glands, thyroid, and neck. He has additional expertise in microvascular reconstruction following head and neck cancer surgery and minimally invasive robotic surgery for removal of tumors in the throat through the mouth (Transoral Robotic Surgery). He also performs advanced craniofacial trauma and skull base surgery. Dr. Cannon is dedicated to providing each patient with the absolute best possible outcome and treating patients with the same care he would provide members of his own family.

Dr. Cannon graduated cum laude from Pomona College, where he was inducted into the Phi Beta Kappa honor society, followed by medical school at the University of Texas Health Science Center at San Antonio, where he was inducted into the prestigious Alpha Omega Alpha honor medical society. He completed his residency training at the University of Utah, where he held the position of chief resident. He then completed his fellowship training at the University of Washington in Seattle with the world-renowned head and neck cancer and reconstructive surgeon, Neal D. Futran, MD, DMD.

Since completing his training, Dr. Cannon has dedicated himself to advanced reconstructive and oncologic care for patients with head and neck cancer. He is passionate about clinical outcomes research utilizing large national databases, in an effort to improve cancer survival. His research focuses on treatment for head and neck tumors and rehabilitation through surgery. Dr. Cannon has authored numerous studies in medical journals and book chapters, as well as given several national presentations related to living through head and neck cancer with the best functional and quality of life outcomes possible. He serves on the national committees (AAO-HNS) for Head and Neck Surgery and Oncology and (AHNS) Publications. Since his appointment at the University of Utah, he has worked towards improving patient’s outcomes, safety, and satisfaction. He is also on the University of Utah Robotic Surgery committee and currently serves as the medical director of the Huntsman Cancer Hospital’s inpatient surgical floor. Dr. Cannon also serves as the H&N Oncology Fellowship Director.

Dr. Cannon likes living in the Wasatch Mountains, where he enjoys water and snow skiing, biking, hiking, running, and playing soccer.

Board Certification and Academic Information

Academic Departments Otolaryngology: Head & Neck Surgery -Associate Professor (Clinical)
Board Certification
American Board of Otolaryngology - Head and Neck Surgery

Education history

Fellowship Head and Neck Surgical Oncology with Microvascular Reconstruction and Advanced Robotic Surgery - University of Washington School of Medicine Fellow
Chief Resident Otolaryngology - University of Utah School of Medicine Chief Resident
Residency Otolaryngology - University of Utah School of Medicine Resident
Professional Medical Medicine - University of Texas Health Science Center at San Antonio M.D.
Undergraduate Major: Biology; Minor: Mathematics - Pomona College B.A.

Selected Publications

Journal Article

  1. Keefe K, McCrary HC, Wei M, Mark B, Drejet S, Cannon RB, Buchmann LO, Hunt JP, Dodson M, Deshmukh V, Newman M, Monroe MM, Hashibe M (2024). Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study. Oral Oncol, 159, 107041.
  2. Bellamkonda N, Farlow JL, Haring CT, Sim MW, Seim NB, Cannon RB, Monroe MM, Agrawal A, Rocco JW, McCrary HC (2024). Evaluating the Accuracy of ChatGPT in Common Patient Questions Regarding HPV+ Oropharyngeal Carcinoma. Ann Otol Rhinol Laryngol, 133(9), 814-819.
  3. Khurana N, Babajanian E, McCrary H, Pulsipher A, Ghandehari H, Alt JA, Cannon RB (2023). Vascular permeability in HPV+ oropharyngeal cancers aids in fluorescent image-guided transoral robotic surgery using indocyanine green. Head Neck, 45(7), 1728-1740.
  4. Rock CB, Hutten RJ, Weil CR, Lloyd S, Kerrigan KC, Cannon RB, Hitchcock YJ (2022). Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottis treated with definitive radiation alone versus chemoradiation. Head Neck, 45(2), 431-438.
  5. Dunklebarger MF, McCrary H, King B, Carpenter P, Buchmann L, Hunt J, Cannon R (2022). Success of Implantable Doppler Probes for Monitoring Buried Free Flaps. Otolaryngol Head Neck Surg, 167(3), 452-456.
  6. Hu B, Patel JL, Tao R, Cannon RB, Monroe M, Goyal G (2022). Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation. J Natl Compr Canc Netw, 20(6), 1-4.
  7. Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock YJ (2021). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head Neck, 44(3), 606-614.
  8. Carpenter P, McCrary HC, Aylward A, Cerrati E, Hunt JP, Buchmann LO, Cannon RB (2021). Penetrating Trauma Rapid Estimated Disability Scale: Assessing Facial Self-Inflicted Gunshot Wounds. Facial Plast Surg Aesthet Med, 23(6), 455-459.
  9. McCrary HC, McLean SR, Luman A, OSullivan P, Smith B, Cannon RB (2021). A National Survey of Robotic Surgery Training Among Otolaryngology-Head and Neck Surgery Residents. Ann Otol Rhinol Laryngol, 130(9), 1085-1092.
  10. Cash H, Harbison RA, Futran N, Parvathaneni U, Laramore GE, Liao J, Cannon R, Rodriguez C, Houlton JJ (2020). Neutron Therapy for High-Grade Salivary Carcinomas in the Adjuvant and Primary Treatment Setting. Laryngoscope, 131(3), 541-547.
  11. McCrary HC, Newberry CI, Casazza GC, Cannon RB, Ramirez AL, Meier JD (2020). Evaluation of opioid prescription patterns among patients undergoing thyroid surgery. Head Neck, 43(3), 903-908.
  12. Harbison RA, Gray AJ, Westling T, Carone M, Rodriguez CP, Futran ND, Cannon RB, Houlton J (2019). The role of elective neck dissection in high-grade parotid malignancy: A hospital-based cohort study. Laryngoscope, 130(6), 1487-1495.
  13. Aylward A, Park J, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Rowe K, Snyder J, Deshmukh V, Newman M, Wan Y, Fraser A, Smith K, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM (2020). Individualized prediction of late-onset dysphagia in head and neck cancer survivors. Head Neck, 42(4), 708-718.
  14. McCrary HC, Cannon RB, Buchmann LO (2019). Some Considerations in Treating Malignant Head and Neck Paragangliomas-Reply. JAMA Otolaryngol Head Neck Surg, 146(2), 210-211.
  15. Aylward A, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM (2019). Rates of Dysphagia-Related Diagnoses in Long-Term Survivors of Head and Neck Cancers. Otolaryngol Head Neck Surg, 161(4), 643-651.
  16. McCrary HC, Babajanian E, Calquin M, Carpenter P, Casazza G, Naumer A, Greenberg S, Kohlmann W, Cannon R, Monroe MM, Hunt JP, Buchmann L (2019). Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades. JAMA Otolaryngol Head Neck Surg, 145(7), 641-646.
  17. Cannon RB, Kull AJ, Carpenter PS, Francis S, Buchmann LO, Monroe MM, Lloyd S, Hitchcock YJ, Cannon D, Weis JR, Houlton JJ, Hunt JP (2019). Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database. Head Neck, 41(6), 1873-1879.
  18. Gobillot TA, Kaka AS, Patel SA, Rodriguez C, Cannon RB, Futran ND, Houlton JJ (2018). Treatment of Tonsillar Carcinoma following Nononcologic Tonsillectomy: Efficacy of Transoral Robotic Revision Tonsillectomy. Otolaryngol Head Neck Surg, 160(4), 627-634.
  19. Dundar Y, Cannon R, Wiggins R, Monroe MM, Buchmann LO, Hunt JP (2018). Orbital invasion routes of non-melanoma skin cancers and survival outcomes. Orbit, 37(6), 405-410.
  20. Carpenter PS, Shepherd HM, McCrary H, Torrecillas V, Kull A, Hunt JP, Monroe MM, Buchmann LO, Cannon RB (2018). Association of Celecoxib Use With Decreased Opioid Requirements After Head and Neck Cancer Surgery With Free Tissue Reconstruction. JAMA Otolaryngol Head Neck Surg, 144(11), 988-994.
  21. Cannon RB, Shepherd HM, McCrary H, Carpenter PS, Buchmann LO, Hunt JP, Houlton JJ, Monroe MM (2018). Association of the Patient Protection and Affordable Care Act With Insurance Coverage for Head and Neck Cancer in the SEER Database. JAMA Otolaryngol Head Neck Surg, 144(11), 1052-1057.
  22. Cannon RB, Houlton JJ, Patel S, Raju S, Noble A, Futran ND, Parvathaneni U, Mndez E (2018). Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). Oral Oncol, 86, 296-300.
  23. Torrecillas V, Shepherd HM, Francis S, Buchmann LO, Monroe MM, Lloyd S, Cannon D, Hitchcock YJ, Weis JR, Hunt JP, Houlton JJ, Cannon RB (2018). Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database. Oral Oncol, 85, 1-7.
  24. Cannon RB, Carpenter PS, Boothe D, Buchmann LO, Hunt JP, Lloyd S, Hitchcock YJ, Houlton JJ, Weis JR, Shepherd HM, Monroe MM (2018). Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis. Otolaryngol Head Neck Surg, 159(3), 473-483.
  25. Dundar Y, Cannon RB, Hunt JP, Monroe M, Suneja G, Hitchcock YJ (2018). Radiotherapy regimens in patients with nonmelanoma head and neck skin cancers. Int J Dermatol, 57(4), 441-448.
  26. Thomas AJ, Larson MO, Braden S, Cannon RB, Ward PD (2017). Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial. JAMA Facial Plast Surg, 20(2), 141-147.
  27. Cannon RB, Houlton JJ, Mendez E, Futran ND (2017). Methods to reduce postoperative surgical site infections after head and neck oncology surgery. Lancet Oncol, 18(7), e405-e413.
  28. Sowder JC, Cannon RB, Buchmann LO, Hunt JP, Hitchcock Y, Lloyd S, Grossmann KF, Monroe MM (2017). Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study. Head Neck, 39(5), 876-880.
  29. Dundar Y, Cannon RB, Monroe MM, Buchmann LO, Hunt JP (2016). Skull Base Invasion Patterns and Survival Outcomes of Nonmelanoma Skin Cancers. J Neurol Surg B Skull Base, 78(2), 164-172.
  30. Cannon RB, Dundar Y, Thomas A, Monroe MM, Buchmann LO, Witt BL, Sowder AM, Hunt JP (2017). Elective Neck Dissection for Head and Neck Cutaneous Squamous Cell Carcinoma with Skull Base Invasion. Otolaryngol Head Neck Surg, 156(4), 671-676.
  31. Cannon RB, Wiggins RH 3rd, Witt BL, Dundar Y, Johnston TM, Hunt JP (2017). Imaging and Outcomes for a New Entity: Low-Grade Sinonasal Sarcoma with Neural and Myogenic Features. J Neurol Surg Rep, 78(1), e15-e19.
  32. Cannon RB, Sowder JC, Buchmann LO, Hunt JP, Hitchcock YJ, Lloyd S, Grossman KF, Monroe MM (2017). Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: A population-based study. Head Neck, 39(1), 82-91.
  33. Cannon RB, Thomson RS, Shelton C, Gurgel RK (2016). Long-term Outcomes After Middle Fossa Approach for Traumatic Facial Nerve Paralysis. Otol Neurotol, 37(6), 799-804.
  34. Buchmann L, Ashby S, Cannon RB, Hunt JP (2015). Psychosocial distress in patients with thyroid cancer. Otolaryngol Head Neck Surg, 152(4), 644-9.
  35. Cannon RB, Gurgel RK, Warren FM, Shelton C (2015). Facial nerve outcomes after middle fossa decompression for Bell's palsy. Otol Neurotol, 36(3), 513-8.

Review

  1. McCrary HC, Dunklebarger MF, Fechter BJ, Drejet SM, Monroe MM, Buchmann LO, Hunt JP, Cannon RB (2024). Early ambulation after fibular free flap surgery is associated with reduced length of stay, increased mobility independence, and discharge to home. [Review]. Head Neck, 46(5), 1160-1167.

Book Chapter

  1. Hunt JP, Cannon RB (2016). Parathyroid Carcinoma. In David JT, William D (Eds.), Thyroid and Parathyroid Diseases: Medical and Surgical Management (2nd Edition). Thieme Medical Publishers, Inc.
  2. Cannon RB, McCrary HC, Sharma J, Carpenter PS (). Infection Peri Microsurgical Head and Neck Reconstruction. In Wei FC, El Deek N, Meningaud JP, Futran ND (Eds.), Mastery of Microsurgical Reconstruction of the Head and Neck. New York, NY: Thieme Medical Publishers, Inc.
  3. McCrary HC, Monroe MM, Cannon RB (). Head and Neck Neoplasms. In Karsy M, Abou-Al-Shaar H, Guan J, and Nirula R (Eds.), The Surgical Handbook (pp. 144-152). New York, NY: Thieme Medical Publishers, Inc.
  4. Babajanian E, McCrary HC, Cannon RB (). Airway Management/Tracheostomy. In Karsy M, Abou-Al-Shaar H, Guan J, and Nirula R (Eds.), The Surgical Handbook (pp. 101-108). New York, NY: Thieme Medical Publishers, Inc.

Case Report

  1. Cohen MA, Cannon RB, Couldwell WT (2020). Resection of Invasive Sphenoorbital and Cavernous Sinus Meningioma via Frontotemporal Craniotomy. World Neurosurg, 141, 252.
  2. Cannon RB, Wiggins RH 3rd, Witt BL, Dundar Y, Johnston TM, Hunt JP (2017). Imaging and Outcomes for a New Entity: Low-Grade Sinonasal Sarcoma with Neural and Myogenic Features. J Neurol Surg Rep, 78(1), e15-e19.

Letter

  1. McCrary HC, Cannon RB, Buchmann LO (2019). Response Regarding Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades [Letter to the editor]. JAMA Otolaryngol Head Neck Surg.
  2. Cannon RB, Shelton C, Gurgel RK (2017). Response Regarding Combined Transmastoid and Middle Fossa Approach. [Letter to the editor]. Otol Neurotol, 38(2), 304.

Other

  1. Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock YJ (2021). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head Neck (44(3), pp. 606-614). United States.
  2. Dundar Y, Cannon RB, Monroe MM, Buchmann LO, Hunt JP (2016). Erratum: Skull Base Invasion Patterns and Survival Outcomes of Nonmelanoma Skin Cancers. J Neurol Surg B Skull Base (78(2), pp. e2-e4). Germany.